Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients.
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients. Eur J Cancer. 2024 Mar; 199:113530.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Melanoma
authors with profiles
Ezra Cohen